Giovanna Li Petri

Giovanna Li Petri


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Stella CascioferroStella Cascioferro
Stella Cascioferro
GPGiovanna Li Petri
Giovanna Li Petri
BPBarbara Parrino
Barbara Parrino
BHBtissame El Hassouni
Btissame El Hassouni
Daniela CarboneDaniela Carbone
Daniela Carbone
PDPatrizia Diana
Patrizia Diana
A new series of imidazo[2,1-b][1,3,4]thiadiazole derivatives was efficiently synthesized and screened for their in vitro antiproliferative activity on a panel of pancreatic ductal adenocarcinoma (PDAC) cells, including SUIT-2, Capan-1 and Panc-1. Compounds 9c and 9l, showed relevant in vitro antiproliferative activity on all three pre-clinical models with half maximal inhibitory concentration (IC50) ranging from 5.11 to 10.8 µM, while the compounds 9e and 9n were active in at least one cell line. In addition, compound 9c significantly inhibited the migration rate of SUIT-2 and Capan-1 cells in the scratch wound-healing assay. In conclusion, our results will support further studies to increase the library of imidazo [2,1-b][1,3,4] thiadiazole derivatives for deeper understanding of the relationship between biological activity of the compounds and their structures in the development of new antitumor compounds against pancreatic diseases.

30 May 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
Maria Valeria RaimondiMaria Valeria Raimondi
Maria Valeria Raimondi
Alessandro PresentatoAlessandro Presentato
Alessandro Presentato
GPGiovanna Li Petri
Giovanna Li Petri
MBMiriam Buttacavoli
Miriam Buttacavoli
ARAgnese Ribaudo
Agnese Ribaudo
PCPatrizia Cancemi
Patrizia Cancemi
Pyrrolomycins (PMs) are polyhalogenated antibiotics known as powerful biologically active compounds, yet featuring high cytotoxicity. The present study reports the antibacterial and antitumoral properties of new chemically synthesized PMs, where the three positions of the pyrrolic nucleus were replaced by nitro groups, aiming to reduce their cytotoxicity while maintaining or even enhancing the biological activity. Indeed, the presence of the nitro substituent in diverse positions of the pyrrole determined an improvement of the minimal bactericidal concentration (MBC) against Gram-positive (i.e., Staphylococcus aureus) or -negative (i.e., Pseudomonas aeruginosa) pathogen strains as compared to the natural PM-C. Moreover, some new nitro-PMs were as active as or more than PM-C in inhibiting the proliferation of colon (HCT116) and breast (MCF 7) cancer cell lines and were less toxic towards normal epithelial (hTERT RPE-1) cells. Altogether, our findings contribute to increase the knowledge of the mode of action of these promising molecules and provide a basis for their rationale chemical or biological manipulation.